New insights into the pathophysiology of dyslipidemia in type 2 diabetes.

@article{Taskinen2015NewII,
  title={New insights into the pathophysiology of dyslipidemia in type 2 diabetes.},
  author={Marja-Riitta Taskinen and Jan Bor{\'e}n},
  journal={Atherosclerosis},
  year={2015},
  volume={239 2},
  pages={483-95}
}
Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality for patients with type 2 diabetes, despite recent significant advances in management strategies to lessen CVD risk factors. A major cause is the atherogenic dyslipidemia, which consists of elevated plasma concentrations of both fasting and postprandial triglyceride-rich lipoproteins (TRLs), small dense low-density lipoprotein (LDL) and low high-density lipoprotein (HDL) cholesterol. The different components of… CONTINUE READING